The 14th European Multiple Myeloma Academy (EMMA) was held in Madrid, Spain from 16–17 September, 2016. The programme covered basic and clinical multiple myeloma (MM) research, and consisted of formal presentations, workshops and roundtable discussions. The key themes addressed during the meeting were the biology of MM, current and novel treatment options, and supportive care.
The coverage of this meeting has been supported by Celgene and Amgen through an unrestricted educational grant to the Video Journal of Hematological Oncology.
By choosing to continue, you are confirming that you are a healthcare professional